Further adjustment for N-terminal pro-brain natriuretic peptide (NT-proBNP) (n = 1346) did not substantially alter the risk estimates as follows: chemerin was strongly associated with HF risk (HR per doubling chemerin: 5.36; 95%-CI: 2.52–11.4; p < 0.0001) and omentin-1 was not significantly related to HF in the overall study population (HR doubling omentin-1:1.24; 95%-CI: 0.80–1.93; p = 0.33). This evidence concerns the gene RARRES2 and hydrops fetalis.